2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1870
Neoplasms
1254
Colorectal Neoplasms
1057
Carcinoma, Non-Small-Cell Lung
1012
Stomach Neoplasms
801
Carcinoma, Hepatocellular
784
Lung Neoplasms
768
Prostatic Neoplasms
697
Pancreatic Neoplasms
578
Rectal Neoplasms
447
Ovarian Neoplasms
406
Colonic Neoplasms
405
Uterine Cervical Neoplasms
400
Neoplasm Metastasis
400
Recurrence
380
Leukemia, Myeloid, Acute
372
Esophageal Neoplasms
363
Multiple Myeloma
339
Lymphoma
335
Head and Neck Neoplasms
329
Melanoma
312
Precursor Cell Lymphoblastic Leukemia-Lymphoma
292
Brain Neoplasms
263
Urinary Bladder Neoplasms
254
Liver Neoplasms
225
Nasopharyngeal Carcinoma
223
Leukemia
218
Lymphoma, Large B-Cell, Diffuse
215
Polycystic Ovary Syndrome
210
Squamous Cell Carcinoma of Head and Neck
204
Interventions
Denosumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Osteopetrosis, Autosomal Recessive 7
×
Clear all
NCT03691311
2021-11-03
D-BIOMARK
Institut Català d'Oncologia
Phase EARLY_PHASE1
Unknown
60 enrolled